Complete title: Hematopoietic Stem Cell Transplantation from Haploidentical Donors in Patients with Hematological Malignancies Using a Treosulfan-Based Preparative Regimen
Research Study Number | RG1005742 |
Principal Investigator | Filippo Milano |
Phase | II |
stem cells. When the healthy stem cells from a donor are infused into the patient, they may help the patient`s
bone marrow make stem cells, red blood cells, white blood cells, and platelets. The donated stem cells may also replace the patient`s immune cells and help destroy any remaining cancer cells.
Other eligibility criteria may apply.
Research Study Number | RG1005742 |
Keywords: Leukemia, Acute Lymphoblastic (ALL); Leukemia, Acute Myeloid (AML); Lymphoma, Burkitt; Lymphoma, Hodgkin; Myelodysplastic Syndromes (MDS); Leukemia, Lymphoid; Lymphoma, Mantle-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Follicular; Lymphoma, Small Lymphocytic (SLL); Leukemia, Prolymphocytic; Lymphoma, Lymphoblastic (LBL); Lymphoma, Marginal Zone
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.